There was no statistically significant difference in the serum level of OX40 in NMO patients in comparison to healthy subjects (2.54 ± 1.67 vs. 1.49 ± 0.54 ng/ml; P = 0.11; Fig. 2). The gene discussed is TNFRSF4; the disease is neuromyelitis optica.